blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0531026

EP0531026 - Hexahydrobenzo[f]quinolinones as 5-alpha-reductase inhibitors [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  24.09.1999
Database last updated on 04.06.2024
Most recent event   Tooltip24.09.1999No opposition filed within time limitpublished on 10.11.1999 [1999/45]
Applicant(s)For all designated states
ELI LILLY AND COMPANY
Lilly Corporate Center
Indianapolis, IN 46285 / US
[N/P]
Former [1993/10]For all designated states
ELI LILLY AND COMPANY
Lilly Corporate Center
Indianapolis, Indiana 46285 / US
Inventor(s)01 / Hirsch, Kenneth Steven
6473 Haviland Mill Road
Clarksville, Maryland 21029 / US
02 / Jones, Charles David
223 East Brunswick Avenue
Indianapolis, Indiana 46227 / US
[1993/10]
Representative(s)Tapping, Kenneth George, et al
Lilly Industries Limited European Patent Operations Erl Wood Manor Windlesham
Surrey GU20 6PH / GB
[N/P]
Former [1993/10]Tapping, Kenneth George, et al
Lilly Industries Limited European Patent Operations Erl Wood Manor
Windlesham Surrey GU20 6PH / GB
Application number, filing date92307636.820.08.1992
[1993/10]
Priority number, dateUS1991074813421.08.1991         Original published format: US 748134
US1991078016621.10.1991         Original published format: US 780166
[1993/10]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP0531026
Date:10.03.1993
Language:EN
[1993/10]
Type: B1 Patent specification 
No.:EP0531026
Date:18.11.1998
Language:EN
[1998/47]
Search report(s)(Supplementary) European search report - dispatched on:EP21.01.1993
ClassificationIPC:C07D221/10, A61K31/435
[1993/10]
CPC:
C07D221/10 (EP,US); C07D215/06 (KR); A61P43/00 (EP)
Designated contracting statesDE,   FR,   GB,   IT [1998/50]
Former [1993/10]AT,  BE,  CH,  DE,  DK,  FR,  GB,  IE,  IT,  LI,  LU,  NL,  PT,  SE 
TitleGerman:Hexahydrobenzo(f)quinolinone als 5-alpha-reduktase Inhibitoren[1993/10]
English:Hexahydrobenzo[f]quinolinones as 5-alpha-reductase inhibitors[1993/10]
French:Hexahydrobenzo(f)quinolinones comme inhibiteurs de 5-alpha-réductase[1993/10]
Examination procedure20.08.1992Examination requested  [1993/10]
17.01.1997Despatch of a communication from the examining division (Time limit: M06)
16.06.1997Reply to a communication from the examining division
03.02.1998Despatch of communication of intention to grant (Approval: Yes)
03.04.1998Communication of intention to grant the patent
15.06.1998Fee for grant paid
13.08.1998Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time
05.09.1998Fee for publishing/printing paid
Opposition(s)19.08.1999No opposition filed within time limit [1999/45]
Request for further processing for:05.09.1998Request for further processing filed
05.09.1998Full payment received (date of receipt of payment)
Request granted
21.09.1998Decision despatched
Fees paidRenewal fee
05.07.1994Renewal fee patent year 03
07.07.1995Renewal fee patent year 04
26.07.1996Renewal fee patent year 05
21.07.1997Renewal fee patent year 06
04.07.1998Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[AD]EP0102046  (SCHERING CORP [US]);
 [AD]EP0230967  (HOFFMANN LA ROCHE [CH]);
 [AD]GB2207135  (HOFFMANN LA ROCHE)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.